the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer
Official Title Platform Phase 1 Study Investigating the Safety of Stereotactic Body Radiotherapy (SBRT) With Immuno-oncology Agents for the Treatment of Multiple Metastases in Advanced Solid Tumors
Principal Investigator Luke, Jason
Brief Summary Study to determine the best dose of stereotactic body radiation therapy (SBRT) to be administered in combination with immunotherapy drugs including urelumab, cabiralizumab and nivolumab .
Gender All
Ages 18 Years
Enrollment 60
Accepts Healthy Volunteers No
Lead Sponsor University of ChicagoOther
Collaborator Bristol-Myers SquibbIndustry
Study Design
Study Phase Phase 1
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Cancer
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI